2023 European Cancer Mortality Projections with Emphasis on Lung Cancer
In a study on cancer mortality in Europe for 2023, lung cancer declined in men, while women saw improvements in younger and middle-aged groups. Advancements in tobacco control were noted, and efforts on lifestyle factors and healthcare may reduce cancer mortality in the European Union (EU) by 2035.
This study focused on predicting cancer mortality for 2023 in the EU-27 and emphasized lung cancer. Using data from the World Health Organization and Eurostat databases spanning 1970-2018, the researchers made projections for deaths and age-standardized rates (ASRs) for various cancers in 2023.
Results are shown in the table below:
| Category | Findings for 2023 | Trends from 1989-2023 |
| Cancer Deaths (EU-27) | Predicted: 1,261,990 | Avoided 5,862,600 deaths compared to
1988 peak rates |
| Lung Cancer Mortality | Men: 6.5% decrease (ASR: 123.8/100,000) | All age groups in men: Decline |
| Women: 3.7% decrease (ASR: 79.3/100,000) | Women (aged 0-35): 35.8% decrease | |
| Women (aged 35-64): 7% decrease | ||
| Women (aged 65+): 10% increase |
Overall, to conclude,
To sustain and enhance positive trends in cancer mortality within the EU, it is crucial to:
- Continue tobacco control with higher cigarette prices and age restrictions.
- Identify at-risk populations for lung cancer screening.
- Address overweight, obesity, and alcohol consumption.
- Promote organized screening for breast, colorectal, and cervical cancers.
- Encourage hepatitis B and human papillomavirus vaccination.
- Prioritize HBV and HCV treatment and HCV elimination.
- Focus on countries with the highest cancer mortality gaps.
- Meeting the 35% reduction target in cancer mortality by 2035 is feasible with current trends.
Reference Link: